Tirzepatide
Price range: £50.00 through £95.00
CAS No: 2023788-19-2
Strengths Available: 30mg/40mg/50mg/60/mg
Format: Sealed containment / vial presentations available
Volume: 3mL
What Tirzepatide is about?
Tirzepatide is a research-grade peptide studied in the context of metabolic signalling, energy balance, and related receptor pathways. Investigators have explored how Tirzepatide interacts with pathways relevant to glucose handling, appetite regulation, or lipid metabolism in laboratory models.
Description
What is Tirzepatide ?
Tirzepatide is a research-grade peptide studied in the context of metabolic signalling, energy balance, and related receptor pathways. Investigators have explored how Tirzepatide interacts with
pathways relevant to glucose handling, appetite regulation, or lipid metabolism in laboratory models.
Why Tirzepatide Attracted Research Interest
Researchers became interested in Tirzepatide because of its relevance to metabolic regulation and the study of energy-balance pathways. It provides a defined research tool for examining metabolic signalling in experimental models.
Key Research Focus Areas
- Metabolic and energy-balance signalling models
- Glucose and lipid metabolism research
- Appetite and satiety pathway studies
- Receptor-binding and pathway investigations
- Body-composition research models
- Mitochondrial and cellular-energy research
What the Research Has Shown
In preclinical research, Tirzepatide has been studied for its influence on metabolic signalling and energy-balance pathways. Mechanistic studies have explored its interaction with receptors and pathways central to metabolic regulation.
Scientific Background and Research Context
Tirzepatide is a synthetic peptide studied as a dual GIP and GLP-1 receptor agonist. GIP stands for glucose-dependent insulinotropic polypeptide, while GLP-1 stands for glucagon-like peptide-1. Both are incretin hormones involved in nutrient response, insulin signalling, appetite regulation, and metabolic control. FDA prescribing information describes Tirzepatide as a once-weekly GIP receptor and GLP-1 receptor agonist.
Tirzepatide attracted major scientific interest because it combines activity at two metabolic signalling pathways in a single molecule. GLP-1 receptor activation has long been studied for glucose regulation, reduced glucagon secretion, slowed gastric emptying, and appetite signalling. GIP receptor activity is also relevant to insulin secretion and adipose-tissue metabolism. The dual-action approach made tirzepatide an important compound in research into type 2 diabetes, obesity, body-composition science, and cardiometabolic regulation.
Exploring the Science Behind GLP-1
The scientific rationale behind tirzepatide is based on the idea that GIP and GLP-1 signalling may have complementary effects. GLP-1 pathways are strongly linked with satiety, glucose-dependent insulin release, and reduced glucagon activity. GIP receptors are found in adipose tissue and are studied for their possible role in lipid handling, insulin sensitivity, and post-meal nutrient storage. In clinical research, combining GIP and GLP-1 receptor agonism has been hypothesised to produce greater effects on glucose control and body weight than GLP-1 activation alone.
Tirzepatide is structurally based mainly on the GIP amino-acid sequence and includes a fatty acid component that supports albumin binding and prolongs its half-life, allowing once-weekly administration.
Research Context in Metabolic and Body-Composition Science
Tirzepatide has been widely studied in metabolic research, especially in relation to type 2 diabetes, obesity, body weight regulation, and cardiometabolic risk markers. In the SURPASS-2 trial, Tirzepatide was compared with Semaglutide in patients with type 2 diabetes and showed strong effects on HbA1c and body-weight outcomes.
In obesity research, the SURMOUNT-1 trial studied once-weekly Tirzepatide in adults with obesity or overweight without diabetes. The trial reported substantial and sustained body-weight reductions over 72 weeks, making Tirzepatide one of the most closely watched compounds in modern body-composition and metabolic science.
Ongoing Scientific Interest
Current research interest in tirzepatide extends beyond weight and glucose outcomes. Scientists continue to investigate how dual GIP/GLP-1 receptor agonism may affect appetite signalling, insulin sensitivity, adipose-tissue biology, liver fat, inflammatory markers, cardiovascular outcomes, kidney-related endpoints, and long-term metabolic health.
Tirzepatide is therefore an important reference compound in modern incretin research. It represents a shift from single-pathway GLP-1 receptor agonism toward multi-receptor metabolic signalling, where several hormone pathways are targeted together to better understand energy balance and cardiometabolic regulation.
For research and laboratory use only. Not for human or veterinary use.
Ingredient Profile
Single research compound: Tirzepatide
CAS: 2023788-19-2
Purity >99%
Supplied as lyophilised powder (no excipients, fillers or additives).
Active Ingredients
Tirzepatide — 30 / 40 / 50 / 60mg
Ingredient Breakdown
Tirzepatide: 30 / 40 / 50 / 60mg of active peptide per vial (lyophilised).
Why is Tirzepatide studied in metabolic research?
Because studies have explored its relevance to metabolic regulation and energy-balance pathways.
Is tirzepatide approved for medical use?
No. It is supplied strictly for research and laboratory use only, and is not intended for human or veterinary use.
Why does purity matter so much for this product?
High purity helps ensure that observed research effects are due to the material itself rather than impurities.
What does ‘research grade’ mean?
It means the product is supplied with documentation and traceability for laboratory investigation.
Is international supply available?
Yes. International fulfilment and temperature controlled shipping can be supported where appropriate.
Research & laboratory use only. Not for human or veterinary use. Not a medicinal product, supplement, food or medical device. No therapeutic, diagnostic, cosmetic, wellness or lifestyle claims are made or implied. Analytical reference/click information is a laboratory measurement aid only and must not be applied to living systems.
Typically supplied at >99% purity, supported by batch-specific analytical data. UK-based preparation, analysis and release under scientist-led, GMP-aligned processes with full batch-level traceability. Certificate of Analysis (CoA) available on request; independent analytical verification where appropriate.
Store the lyophilised powder refrigerated at 2–8°C, protected from light and moisture; suitable for longer-term storage frozen at -20°C. Handle under appropriate laboratory conditions. For in vitro research use only.
For in vitro laboratory research only. Reconstitution, handling and experimental design at the discretion of the qualified researcher. The 300-click sealed-containment system is an analytical measurement reference only and does not represent dosing or administration guidance. Not for use in living systems.
Partner with FreshstartPharma– Where Accuracy Meets Innovation
Freshstartpharma is committed to delivering high-quality research-grade products designed for advanced scientific applications. We offer wholesale partnerships to selected businesses that share our values of integrity, quality, and innovation. Whether you’re an established distributor or an emerging research supply company, we invite you to join our network and benefit from exclusive access to our state-of-the-art product range.
Related Products
CJC-1295 (with DAC)
Selank
Ipamorelin
